Rfx6 directs islet formation and insulin production in mice and humans SB Smith, HQ Qu, N Taleb, NY Kishimoto, DW Scheel, Y Lu, AM Patch, ... Nature 463 (7282), 775-780, 2010 | 278 | 2010 |
Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover … N Taleb, A Emami, C Suppere, V Messier, L Legault, M Ladouceur, ... Diabetologia 59 (12), 2561-2571, 2016 | 82 | 2016 |
Comparison of two continuous glucose monitoring systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite system, at rest and during exercise N Taleb, A Emami, C Suppere, V Messier, L Legault, JL Chiasson, ... Diabetes technology & therapeutics 18 (9), 561-567, 2016 | 58 | 2016 |
The challenges of achieving postprandial glucose control using closed‐loop systems in patients with type 1 diabetes V Gingras, N Taleb, A Roy‐Fleming, L Legault, R Rabasa‐Lhoret Diabetes, Obesity and Metabolism 20 (2), 245-256, 2018 | 48 | 2018 |
Glucagon in artificial pancreas systems: potential benefits and safety profile of future chronic use N Taleb, A Haidar, V Messier, V Gingras, L Legault, R Rabasa‐Lhoret Diabetes, Obesity and Metabolism 19 (1), 13-23, 2017 | 40 | 2017 |
Human epicardial fat expresses glucagon-like peptide 1 and 2 receptors genes G Iacobellis, V Camarena, DW Sant, G Wang Hormone and metabolic research= Hormon-und Stoffwechselforschung= Hormones …, 2017 | 32 | 2017 |
Prevalence and determinants of albuminuria in a cohort of diabetic patients in Lebanon N Taleb, H Salti, M Al-Mokaddam, M Merheb, I Salti, M Nasrallah Annals of Saudi medicine 28 (6), 420-425, 2008 | 26 | 2008 |
Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients HI Salti, MP Nasrallah, NM Taleb, M Merheb, S Haddad, J El-Annan, ... Canadian Journal of Ophthalmology 44 (3), 308-313, 2009 | 24 | 2009 |
Body composition and epicardial fat in type 2 diabetes patients following insulin detemir versus insulin glargine initiation B Elisha, M Azar, N Taleb, S Bernard, G Iacobellis, R Rabasa-Lhoret Hormone and metabolic research 48 (01), 42-47, 2016 | 23 | 2016 |
Body composition and epicardial fat in type 2 diabetes patients following insulin detemir versus insulin glargine initiation B Elisha, M Azar, N Taleb, S Bernard, G Iacobellis, R Rabasa-Lhoret Hormone and metabolic research 48 (01), 42-47, 2016 | 23 | 2016 |
Timing of insulin basal rate reduction to reduce hypoglycemia during late post-prandial exercise in adults with type 1 diabetes using insulin pump therapy: a randomized … A Roy-Fleming, N Taleb, V Messier, C Suppère, C Cameli, S Elbekri, ... Diabetes & metabolism 45 (3), 294-300, 2019 | 21 | 2019 |
The benefits and limits of technological advances in glucose management around physical activity in patients type 1 diabetes S Tagougui, N Taleb, R Rabasa-Lhoret Frontiers in endocrinology 9, 818, 2019 | 19 | 2019 |
Vascular complications of diabetes in Lebanon: experience at the American University of Beirut N Taleb, H Salti, M Al-Mokaddam, M Merheb, I Salti, M Nasrallah The British Journal of Diabetes & Vascular Disease 8 (2), 80-83, 2008 | 17 | 2008 |
Changes in accuracy of continuous glucose monitoring using Dexcom G4 Platinum over the course of moderate intensity aerobic exercise in type 1 diabetes S Larose, R Rabasa-Lhoret, A Roy-Fleming, C Suppère, S Tagougui, ... Diabetes technology & therapeutics 21 (6), 364-369, 2019 | 10 | 2019 |
Artificial pancreas systems and physical activity in patients with type 1 diabetes: challenges, adopted approaches, and future perspectives S Tagougui, N Taleb, J Molvau, É Nguyen, M Raffray, R Rabasa-Lhoret Journal of diabetes science and technology 13 (6), 1077-1090, 2019 | 9 | 2019 |
Can somatostatin antagonism prevent hypoglycaemia during exercise in type 1 diabetes? N Taleb, R Rabasa-Lhoret Diabetologia 59 (8), 1632-1635, 2016 | 9 | 2016 |
Stability of commercially available glucagon formulation for dual-hormone artificial pancreas clinical use N Taleb, A Coriati, C Khazzaka, J Bayonne, V Messier, R Rabasa-Lhoret Diabetes technology & therapeutics 19 (10), 589-594, 2017 | 8 | 2017 |
RFX6 is needed for the development and maintenance of the β-cell phenotype N Taleb, C Polychronakos Islets 3 (5), 291-293, 2011 | 7 | 2011 |
wang J SB Smith, HQ Qu, N Taleb, NY Kishimoto, LY Scheel Dw, AM Patch, ... Lynn FC, Miyatsuka T, Mitchell J, Seerke R, Desir J, vanden eijnden S …, 2010 | 7 | 2010 |
Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: results of an online survey N Taleb, V Messier, S Ott-Braschi, JL Ardilouze, R Rabasa-Lhoret Diabetes research and clinical practice 144, 42-50, 2018 | 6 | 2018 |